Musculoskeletal pain is a common cause of work absence, and early intervention is advocated to prevent the adverse health and economic consequences of longer-term absence. This cluster randomised controlled trial investigated the effect of introducing a vocational advice service into primary care to provide occupational support. Six general practices were randomised; patients were eligible if they were consulting their general practitioner with musculoskeletal pain and were employed and struggling at work or absent from work ,6 months. Practices in the intervention arm could refer patients to a vocational advisor embedded within the practice providing a case-managed stepwise intervention addressing obstacles to working. The primary outcome was number of days off work, over 4 months. Participants in the intervention arm (n 5 158) had fewer days work absence compared with the control arm (n 5 180) (mean 9.3 [SD 21·7] vs 14·4 [SD 27·7]) days, incidence rate ratio 0·51 (95% confidence interval 0·26, 0·99), P 5 0·048). The net societal benefit of the intervention compared with best care was £733: £748 gain (work absence) vs £15 loss (health care costs). The addition of a vocational advice service to best current primary care for patients consulting with musculoskeletal pain led to reduced absence and cost savings for society. If a similar early intervention to the one tested in this trial was implemented widely, it could potentially reduce days absent over 12 months by 16%, equating to an overall societal cost saving of approximately £500 million (US $6 billion) and requiring an investment of only £10 million.
Introduction
Musculoskeletal pain is one of the most common causes of work absence. 2, 7 Across Europe, almost a quarter of workers will experience pain in their neck, shoulders, or upper limbs, and an estimated half of the European workforce will experience back pain at some point in their lives at a cost of approximately €12 billion overall. 34 The cost of work absence attributed to musculoskeletal pain in European Union countries is between 0.5% and 2.0% of national gross domestic product 34 ; pain also has a considerable impact on individuals' earnings and associated costs to the state in benefit payments. 30 In the United Kingdom, the estimated costs in 2003 for general practitioner (GP) consultations only as a result of musculoskeletal conditions were £1.34 million. 12 The prevalence and incidence of many musculoskeletal conditions increase with older age; this, coupled with the rising retirement age, means that the impact of musculoskeletal pain on the workforce will rise further. 34 Remaining active at work, despite pain, has been demonstrated to be beneficial to individuals and employers resulting in less sickness absence, less time on modified duties, and a reduction in pain recurrence. 30 Intervening early when employees report musculoskeletal pain can have a significant impact on their ability to remain in work. 5, 31 However, the provision of independent occupational health services is scarce, and for the majority of working age people, the first port of call for advice is their GP. 5 In the United Kingdom, the GP is also the gatekeeper to health-related benefits through the "Fit Note" system whereby absence of greater than 7 days is sanctioned. However, many GPs report that they feel ill equipped to manage occupational health issues and have had little or no training in the use of Fit Notes. 16 Previous initiatives to address health and work have
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been aimed primarily at those with longer-term absence. 1, 23 However, given the evidence that the longer an individual is out of work, the less likely it is that they will return, intervening before an individual experiences long-term absence may be beneficial to both the individual and wider society. Primary care is likely to be the ideal setting in which to offer patients early access to appropriate occupational health support, also termed vocational advice, occupational advice, and workplace coaching in the literature. Although there are guidelines in place to support primary care practitioners in providing appropriate advice and support about work, implementation of these is variable. 3 Improvement in training and education about managing occupational health in primary care should be coupled with provision of services to which patients may be referred for advice and assistance about work.
The aim of this cluster randomised controlled trial was to determine whether the addition of a vocational advice (VA) service to best current primary care can reduce work absence in patients consulting their GP for musculoskeletal pain who are either absent from work or struggling to remain in work because of their pain.
Methods

Study design and participants
The methods are reported in full in the published protocol. 4 The Study of Work and Pain (SWAP) was a pragmatic, cluster randomised controlled trial in primary care with 2 parallel arms, an economic evaluation, and linked qualitative interviews (reported separately). The unit of randomisation was the general practice with data collected from individual participants.
Consenting GP practices were randomly assigned to provide either best current primary care for managing the impact of musculoskeletal conditions on work or the same best care plus the addition of a VA service, located in the practice and staffed by trained VAs who provided occupational advice about working with musculoskeletal pain. General practitioner practices were eligible for participation if they were located in the National Institute of Health Research Clinical Research Network: West Midlands (NIHR CRN: WM), which supports delivery of research within primary care practices in the region. Recruitment took place between 2012 and 2014, and participants were followed up 4 and 12 months later. Patients were eligible for participation if they were consulting with musculoskeletal pain, aged 18 to 70 years, currently in paid employment, had current sickness absence due to musculoskeletal pain of less than 6 months duration (either GP or self-certified and either first consultation for a Fit Note or a repeat consultation for a Fit Note), or were considered by the GP or nurse practitioner (NP) to be struggling with work because of musculoskeletal pain. Patients were not eligible for participation if they met any of the following criteria (full criteria are reported in the protocol) 4 : Patients with symptoms indicative of possible serious pathology, requiring urgent medical attention; those who have long-term work absence (greater than 6 months); and those with serious mental health problems. Eligible patients were identified when they consulted their GP/NP and were introduced to the study and given an information pack. The pack contained a letter of invitation, participant information sheet, consent form to participate in the research evaluation of the service, self-completion questionnaire, and a prepaid reply envelope. Eligible patients, not identified during the consultation, were later identified by the NIHR CRN: WM through regular medical record reviews (see published protocol for full details). 4 Selection bias was minimised in this cluster trial through identical methods of participant identification, invitation, and recruitment at both intervention and control practices.
A trial steering committee and independent Data Monitoring Committee oversaw the trial. The National Research Ethics Service West Midlands-Staffordshire in the United Kingdom approved the protocol (REC reference: 12/WM/0020), and the trial was registered at ISRCTN 52269669.
Randomisation and masking
General practitioner practices were the unit of randomisation. Practices were matched on registered population list size; the matched practices were randomly allocated to the intervention or control arms by stratified block randomisation. The randomisation process within the individual blocks was computer generated by the trial statistician. General practitioners, NPs, and VAs could not be masked to allocation. Individual participants were informed that local musculoskeletal services were being evaluated and their consent was sought to participate in data collection and medical record review. The data were analysed independently by 2 statisticians, one of whom was masked to intervention allocation.
Interventions
Both intervention and control practices provided best current work-focussed primary care. The provision of best current care was supported by providing GPs and NPs with an education session lasting 1 hour. This emphasised 4 key messages: (1) work is usually good for people with musculoskeletal pain, (2) long periods of absence are generally harmful, (3) musculoskeletal pain can generally be accommodated at work, and (4) planning and supporting return to work are important aspects of clinical management. 20, 30 The intervention practices also hosted a new VA service, 4 and GPs and NPs could refer patients to the service whether, or not, patients consented to take part in the research evaluation. Patients referred to the VA were contacted 5 working days after referral. Initial contact was by telephone (step 1), with 1 or more face-to-face meetings (step 2) and contact with employers (step 3) being held subsequently, if required. Vocational advisors used the "psychosocial flags framework" 20 to assist patients in identifying and overcoming obstacles to returning to or remaining in work with their musculoskeletal pain. The VAs focussed discussions on 3 main areas: (1) psychological or behavioural obstacles to working, eg, beliefs about pain, illness behaviours (yellow flags) 19 ; (2) work perceptions, eg, the beliefs about the physical and social impact of work on health (blue flags) 28 ; and (3) context factors, eg, objective working conditions and characteristics, and financial impact of working status such as job security and benefit entitlements (black flags). 20 The VA and patient jointly developed a plan to manage health and work issues and to support the patient in addressing identified obstacles, with regular review. The VA also ensured that the patient's GP was included in communications using the practice communications system linked to the patient's medical record. This ensured that clinical issues identified as obstacles to work could be communicated to the GP for resolution and that return-to-work plans could also be provided to the GP. Four health care practitioners were recruited to the VA role to deliver the service; 3 physiotherapists and 1 nurse (all VA was actually delivered by the 3 physiotherapists), all completed a 4-day training course (developed by the study team and reported separately) and half day update before the start of the service. The VAs were new recruits to this role and did not provide any other services to the general practice. The service was "low intensity" and based on the principles of case management using a stepped care model to develop a goal-orientated approach to remaining in or returning to work (Fig. 1) , along with the intention of getting the key players (person, health care, and workplace) onside. 20 Patients continued to be eligible for VA until they achieved a sustained return to work (the patient returns to work and does not initiate contact with the VA for a period of at least 2 weeks) and felt able to manage their musculoskeletal pain in the context of their work, or until they had been absent from the workplace for a total of 6 months and qualified for Employment and Support Allowance.
Outcomes
Demographic data, health, and work data were collected after GP consultation and, in the intervention practices, before an appointment with the VA, and at 4-and 12-month follow-up. Full details of the primary and secondary outcomes collected are provided in the protocol. 4 The primary outcome measure was number of days off work over 4 months, measured at the individual participant level. Work absence was identified at follow-up based on the following self-reported questions: "Have you taken time off work during the last 4 months (since your last questionnaire) because of your pain?," "If yes, please write the number of days, weeks or months you were off work due to your pain in the last 4 months." "Days off work" in this context captures periods of self-certified absence as well as GP-certified absence. For the purposes of this trial, 1 week was classified as 5 days and 1 month as 21 days. Further analysis of time off work examined any self-reported time off work (binary yes/no) and GP-certified periods over 12 months of follow-up identified from the medical record. Secondary outcome measures included pain intensity (0-10 numerical rating scale), bothersomeness (1-5 rating scale), 10 global assessment of change (5-point rating of general health from excellent to poor), selfefficacy to return to work (Self-efficacy to Return-to-Work Questionnaire), 29 work presenteeism (Stanford Presenteeism Scale 6), 21 and self-rated work performance (0-10 numerical rating scale).
Statistical analysis
For the primary outcome (days off work over 4 months), the analysis was by hierarchical negative binomial regression adjusting for age, sex, and GP practice size (at the GP cluster level). 13 The best-fitting model according to goodness-of-fit (higher log likelihood, and lower Akaike information criterion and Bayesian information criteria) was given by a zero-inflated model; hence, the hierarchical zero-inflated negative binomial regression was used for the analysis of time off work over 4 months (primary) and 12 months (secondary). Given the limited number of GP practices, the hierarchical model included individual practitioners (GPs and NPs) at the cluster level; differences in GP behaviours are known to be a major influence in varying sickness certification prescribing practice. 32 Longitudinal mixed models (linear or generalised as appropriate to numerical and categorical outcome data, respectively) were fitted to estimate and test for betweengroup effects across other outcome measures, adjusting for baseline covariates (age, sex, and GP practice size). An intentionto-treat analysis was followed. The statistical analysis followed the plans described in the published protocol, 4 and the final version of the statistical analysis plan agreed with the Data Monitoring Committee.
Sensitivity analyses
(1) Evaluation of the primary outcome measure (number of days off work by robust Poisson and zero-inflated models) (2) Evaluation of the primary outcome measure (number of days off work) by a zero-inflated negative binomial model with robust variance estimator 17 adjusted for (1) age, sex, and practice size and (2) adjusted for age, sex, practice size plus baseline pain scores, and days off work over the past 12 months. (3) Evaluation of the primary outcome measure using the GP practice as the unit of clustering rather than the individual GP/ NP practitioner, including GP practice as a random factor intercept in the hierarchical model. (4) A per protocol evaluation (and complier average causal effect evaluation) comparing time off work for those participants in the intervention practices who engaged with any aspect of the VA service (at least 1 contact with a VA) vs (1) all control arm participants, (2) "comparable" participants in the control practices that would be expected to similarly adhere with treatment protocol-via an instrumental variable analysis (adherence/nonadherence, defined as at least 1 contact with the VA).
Subgroup analyses
Exploratory evaluation of the primary outcome was performed to examine whether time off work appeared differed between subgroups. The 3 subgroup analyses agreed and documented in the statistical analysis plan were baseline return-to-work selfefficacy, location of pain (spinal pain vs pain in other areas), and duration of work absence (at least 10 days vs/less than 10 days). Statistical estimates were obtained through including interaction terms in the statistical model of treatment effect.
Sample size
The sample size calculation was based on the ability to detect a between-group difference of at least 10 days off work at 4 months, given an expected SD of 25 days, 33 80% power, and 5% 2-tailed significance level. The sample size takes into account (1) 30% inflation through clustering of data (at practitioner level) based on an intracluster correlation coefficient for betweenpractitioner effects of 0.05, 22 variation in expected VA service referral rates between GPs (based on an expected coefficient of variation of 0.65), 11 and (2) 25% inflation through allowance for 20% loss to follow-up at 4 months. This resulted in a required sample size of 330 participants (165 per arm).
Economic evaluation
An incremental cost-effectiveness analysis was undertaken using mean days off work as the measure of outcome, to calculate the cost per sick day avoided, from a health care perspective. Patient-level health care costs concentrated on National Health Service (NHS) and private health care resource use for musculoskeletal pain obtained from patient questionnaires at 4 and 12 months, and additional costs of the VA service (eTable 1, available online at http://links.lww.com/ PAIN/A489). Hierarchical modelling was used to estimate differential costs and differential quality-adjusted life years controlling for the treatment arm and clustering. 15 Details of contact with the VAs were obtained through case report forms. Unit cost data relating to resource use are reported in eTable 2 (available online at http://links.lww.com/PAIN/A489), and a price year of 2013 was used, with costs presented in UK pounds (£). A cost-benefit approach was used to generate a net societal benefit and return on investment (ROI) of using the VA service. Wider societal costs in relation to the VA intervention were assigned to self-reported work absence using the human capital approach by multiplying days off work during follow-up by the Standard Occupational Classificationrelated (2010 edition) respondent-specific wage rates. Discounting was not performed because of the 12-month follow-up period.
Public and patient involvement and engagement
Patients with musculoskeletal pain and primary care clinicians involved in their treatment were involved throughout the SWAP trial and were independent from those participating in the trial. Public and patient involvement and engagement representatives were involved in the development of the research question and were active members of the grant application with additional members involved in the trial steering committee and providing advice on all aspects of the design, recruitment, and retention methods, as well as reviewing all patient-facing materials.
Results
Recruitment
Twenty general practices were approached with 6 general practices being eligible; they were randomised, 3 to the intervention and 3 to the control arms. Participants were recruited between July 2012 and January 2014; Figure 2 shows the flow of participants through the trial. A total of 338 participants consented to participate in the research data collection after their consultation at participating practices, 158 to the intervention and 180 to the control arms. Follow-up was 75% (n 5 119) and 69% (n 5 109) at 4 and 12 months, respectively, in the intervention arm and 82% (n 5 148) and 73% (n 5 131) at 4 and 12 months, respectively, in the control arm. Table 1 reports the baseline characteristics of participants, which were comparable. The mean age was 49.5 and 47.9 years, with 56% and 59% women in the intervention and control arms, respectively. Most participants were working full time. Participants in the control arm reported that they had marginally more days of work absence in the previous 12 months. At baseline, duration of symptoms, measures of pain intensity, and bothersomeness were similar in both arms.
Baseline characteristics
Adherence with treatment protocol
Of the 158 participants in the intervention practices, 120 (76%) were referred to the VA service (Fig. 2) . Of these, 97 (81%) had at least 1 contact with a VA. The average number of contacts between the VAs and patients was 2, with the majority of these being telephone contacts (89%) lasting an average of 13.3 minutes ( Table 2) . Exploration of health and work issues were frequently recorded by the VAs on case report forms, but returnto-work planning was not commonly recorded.
Primary outcome
Four months
At 4 months, there was some evidence for effect in the number of days off work between arms with the intervention arm reporting fewer days off work mean of 9.3 (SD 21.7) days compared with 14.4 (SD 27.7) days in the control arm, an adjusted incidence rate ratio (IRR) of 0.51 (P 5 0.048). Results of the sensitivity analyses including different model estimation, nonparametric testing, per protocol/complier average causal effect complier evaluation, and accounting for clustering at GP practice level concurred with the primary analysis in showing greater time (days) off work in the control arm ( Table 3) . The difference in days off work was largely accounted for by the lower number of GP-certified days in the intervention arm at 8.4 (SD 21.0) days vs 13.5 (27.5) days in the control arm (P 5 0.020) ( Table 3) .
Twelve months
By 12 months, there was no overall statistically significant difference in the cumulated number of days of work absence between arms. However, the intervention arm reported fewer days off work certified by the GP at a mean of 16.4 (SD 34.2) days compared with 22.9 (SD 50.5) days in the control arm (P 5 0.018). The control arm reported fewer days self-certified than the intervention arm at a mean of 1.5 (SD 3.3) days compared with 3.9 (SD 15.0) days (P 5 0.001) ( Table 3) . 
Exploratory subgroup analyses
At 12 months, exploratory subgroup analyses showed that the VA service was significantly more successful in those with spinal pain compared with those with other musculoskeletal pain (IRR 0.25, 95% confidence interval 0.10-0.62; P interaction 5 0.003). The intervention was also significantly more successful in those who had work absence that exceeded 10 days at baseline compared with those with absence periods of less than 10 days (IRR 0.30, 95% confidence interval 0.11-0.83; P interaction 5 0.020) ( Table 3) . Baseline level of self-efficacy to return to work had little impact on the effect of the intervention ( Table 3 ).
Secondary outcomes
Self-reported time off work (binary yes/no) was examined as a secondary outcome. Separate analysis compared the proportions of participants in the 2 trial arms issued with a GP-certified fit note, assessed through medical records ( Table 3) . Of the healthrelated (secondary) outcome measures, there were few statistically significant differences between the intervention and control arms for measures of pain, bothersomeness, pain self-efficacy, Illness Perceptions Questionnaire (IPQ-R), Hospital Anxiety and Depression Scale (HADS), and general health. Although estimated differences were small, the health outcomes were generally in favour of the intervention arm ( Table 4) . Work-related measures demonstrated statistically significant differences between arms, in favour of the intervention arm, at both 4 and 12 months in return-to-work selfefficacy and performance at work, and a significant difference in presenteeism at 4 months ( Table 4) .
Economic evaluation
The VA service resulted in greater mean benefits in terms of days off work (6.7 fewer days off work; adjusted difference in time off work over 12 months), at slightly higher NHS and health care costs (cost difference of £48 and £15 for NHS and health care perspectives, respectively) ( Table 5) . From an NHS perspective, this resulted in an incremental cost-effectiveness ratio of £7.20 per day of absence avoided. The net societal benefit of the addition of the VA service compared with best current care alone was £733 (£748 gain [work absenteeism] minus £15 loss [health care-related costs]), demonstrating that the intervention represents more efficient use of resources than the control ( Table 5 ). The corresponding ROI from a societal perspective was £49 (£733 divided by £15) that is, every £1 invested in the VA service will return an estimated £49 ($64USD). The inclusion of training costs and monthly mentoring brings the ROI to £25 ($30USD).
The point estimate suggests that the intervention was more effective (with fewer days off work) and associated with higher costs than the control. eFigure 1 shows that for a willingness to pay of £40 per sick day avoided, the probability that the intervention is cost effective was slightly over 50% (available online at http://links.lww.com/PAIN/A489). 
Discussion
The SWAP trial demonstrated that the addition of a low-intensity, early access, VA service to best current primary care for adults consulting with musculoskeletal pain led to fewer days off work over 4 months, indicating some evidence for effect of the intervention. The intervention improved measures of work performance, presenteeism, and self-efficacy to return to work. Use of the VA service for musculoskeletal pain was associated with slightly higher costs, but the cost-benefit analysis demonstrated the broader societal value of the VA service.
Implications
The VA service, also termed occupational advice and workplace coaching, highlighted 2 key implications relating to the study population and the intensity of intervention delivered.
Timing of the intervention
The sample included in the SWAP trial could be considered early in their "work absence career"; patients were eligible if they were struggling at work as well as those having a short period of absence (less than 6 months). Although the addition of the VA service led to significantly fewer days off work, exploratory subgroup analysis in those participants with ,10 days absence vs $10 days but ,6 months absent at baseline found that the intervention was more successful in those with the longer absence duration. Although early intervention is advocated, 4 these results suggest that a VA intervention might be better targeted to those with more than 10 days (2 working weeks) of absence. van Duijn et al. 9 reviewed the literature around timing of interventions for individuals on sick leave because of back pain, reporting the optimal window in which to intervene as 8 to 12 weeks. These findings suggest the optimum time to provide support in managing health and work is likely to be after 10 days (approximately 2 working weeks) of absence, but this needs testing in future studies.
Intensity of intervention delivered
The intervention provided in the SWAP trial was low intensity with the majority of VA delivered by telephone. This is in keeping with robust evidence that telephone-based VA can help a substantial proportion of cases to self-manage their health problem and may also facilitate return to work. 6 There is evidence that simple, lowintensity interventions provide similar benefits to complex, multimodal interventions whilst avoiding unnecessary medicalisation. This is particularly pertinent to the SWAP trial in which participants had short term or no work absence and were in an ideal position to manage their condition with appropriate advice before their absence became long term. The model of stepped care evaluated in the SWAP trial is similar to that proposed by Burton et al., 6 requiring only those with more complex needs to access costly face-to-face contact.
Strengths and limitations
The SWAP trial has a number of strengths. It is the first trial to evaluate a VA service embedded in general practice offering biopsychosocial advice to people with musculoskeletal pain, a leading cause of work absence. The VA service was also acceptable to patients with 75% (253 patients) of those offered a referral accepting this offer. The SWAP trial is also the first to intervene so early including those who were struggling at work, with the aim of preventing future work absences. Although the stepped care VA service was brief and mainly provided over the telephone, this method is supported by the literature showing that brief VA interventions are as effective as effort-intensive interventions, 25 and there are robust data to support telephonebased interventions. 6 The Department for Work and Pension's evaluation of the Fit For Work service pilots 18 also found that lowcost interventions (equating to low-intensity interventions) were more likely to be the most cost effective, and many of these interventions included populations with longer-term absence, indicating that there would be utility in evaluating a similar VA service in those with longer absence duration. A further strength of this trial concerned activities to ensure continued engagement with general practices. This included a range of measures for both the intervention and control practices comprising; provision of an education session around managing health and work before the trial commenced; regular contact with the trial team GP; a GP "champion" in each practice who was the point of contact for the trial. In intervention practices, VAs actively engaged in practice life, joining breaks and staff meetings and providing both formal and informal feedback about the service to GPs. This was important, given the difficulty in engaging GPs in studies of VA and has been reported by Rannard et al. 26 and the Fit for Work pilots. 18 The finding that there was a difference in GP-certified periods of absence could have been related to the visibility of the VAs in the practice, suggesting that raising the profile of available VA services providing VA may be of benefit. The qualitative analyses conducted alongside this trial was unable to elucidate the reasons for the decrease in the issue of fit notes, 27 and further work is needed to identify whether the availability of a VA service does change GP behaviour reducing the issue of fit notes or Table 2 Summary of VA service delivered. Number of stakeholder contacts 125
Figures are frequency count (percent) unless otherwise specified. * All 17 face-to-face contacts were with 17 different participants (one of these face-to-face contacts was carried out in the participant's workplace). † Stakeholder contacts were predominantly discharge letters to general practitioners. ‡ The flags framework is a system for identifying obstacles to working. § Time in minutes. IQR, interquartile range; VA, vocational advice.
whether accessing VA changes patients' behaviour in asking for certified absence. There are several limitations. First, the association between the intervention and the measures of work outcomes (return-to-work self-efficacy, performance, and presenteeism) were influenced by the adjustment of practice size because of the small number of practices, 3 intervention and 3 control (practice size was adjusted for as it was the only stratification variable used in randomisation). Second, although 3 steps were available to the VAs in the delivery of the VA service, only 1 workplace visit was undertaken (step 3), the reasons for which need some consideration. The VAs within the SWAP trial reported that participants were unwilling for them to contact their employers. Many participants were very early in their work absence and some were not currently absent, but struggling at work; the lack of employer visits may reflect the trial population and the primary care setting, where contact between VAs and employers is uncommon, this is a finding in other similar studies. 8 A linked issue relates to the lack of recorded return-towork plans on the case report forms of patients accessing the VA service in the intervention practices; this may be explained by the early nature of the participants' work absence. Although many participants received at least 1 phone call from the VA, many had already made their own plans to return to work and did not wish for the VA to provide them with written documentation of this. Third, there was the potential for recall bias to be introduced when asking participants to recall their work absence over the past months. To examine the potential for the introduction of recall bias, a sensitivity analysis on the number of days off work was performed using the medical record data, which should eliminate recall bias. The findings of this sensitivity analysis again indicated that the number of days off work was reduced in the intervention arm. Last, the costs of presenteeism were not included in the economic evaluation because the Stanford Presenteeism Scale used could not be converted into a monetary value. Goetzel et al. 14 reported that presenteeism accounts for between 18% and 60% of all costs of a range of health conditions. Given that there were significant differences in measures of presenteeism in favour of the intervention, it is likely that our health economic analyses underestimated the cost effectiveness of the VA service. In terms of the cost effectiveness of the intervention and the small differences in costs and days off work, there remained some uncertainty around estimates. A larger sample size would be able to reduce this uncertainty and provide a better cost-effectiveness interpretation. An appropriate threshold for this outcome needs to be determined.
By way of a conservative estimate using data for back and neck pain alone rather than all musculoskeletal pain conditions, 31 million days are lost from work per year in the United Kingdom. 24 If a similar brief VA service was implemented widely, it could potentially reduce this figure by 16%, equating to an overall societal cost saving of approximately £500 million (216 million days lost per year, amounting to an overall saving of $6 billion for the United States). Evaluation of the primary outcome measure (days off work) and key secondary outcomes relating to time off work over 4 and 12 months of follow-up. 
Future research
Future research should build upon the intervention provided in the SWAP trial, refining the timing of the intervention to those who have at least 10 days work absence. Given that the results demonstrate benefits in patients with musculoskeletal pain, developing and testing VA services with broader patient groups in primary care such as those with mental health conditions and cardiovascular disease would also be helpful.
Conclusions
Study of Work and Pain is the first trial to evaluate an intervention embedded in primary care providing early VA, based on biopsychosocial principles, for patients with musculoskeletal pain. The trial demonstrated a reduction in days off work in favour of the VA intervention, an increase in self-efficacy to return to work, reduced presenteeism, and improved performance at work. Greater economic benefits were seen from the addition of the VA intervention compared with best current primary care alone.
